SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > August 2003

« Previous month Next month »

Flamel shares surge on BMS deal

29-Aug-2003 - French company Flamel Technologies has added another high-profile client for its drug delivery technology, spurring another leap in its shares that have already climbed almost...

Study details best practice in QC

29-Aug-2003 - Focusing on quality initiatives helps top-performing pharmaceutical labs reduce manufacturing costs and minimise production time, according to a new study from pharmaceutical research firm Best...

Human proteins made in yeast

29-Aug-2003 - Researchers in the US have managed for the first time to produce a fully human protein - including complex sugar side chains - in a...

Sticky problem for Acambis

29-Aug-2003 - The delivery of millions of doses of Acambis' smallpox vaccine to the US government has been delayed because of a disagreement over the best glue...

Kyorin unveils new oral dose plant

29-Aug-2003 - Japan's Kyorin Pharmaceuticals plans to invest some 8 billion yen (€62.5m) in a new facility to produce tablet and capsule formulations. This will replace an...

IBM unveils R&D productivity package

28-Aug-2003 - IBM has introduced its new InsightLink software, an application created by its IBM Life Sciences and IBM Research divisions to help pharmaceutical companies create searchable...

Edible vaccines closer to market

27-Aug-2003 - Transgenic plant technologies could lead to a revolution in vaccine production and manufacture and, should plant-based vaccines prove effective in clinical trials, this will drive...

Rhodia to close US paracetamol plant

27-Aug-2003 - France's Rhodia is to close a production unit for paracetamol/acetaminophen located within the massive Monsanto manufacturing complex in Luling, Louisiana, US. However, the company re-affirmed...

UK relaxes salt/ester rules for generics

27-Aug-2003 - The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has stepped back from its requirement that generic products based on a different salt or ester...

New lutetium-177 source for cancer drugs

27-Aug-2003 - Supplies of a radioisotope that could provide the radiation payload for a new generation of cancer treatments have improved, now that International Isotopes has entered...

German health reforms drive out Pfizer, Merck

27-Aug-2003 - US pharmaceuticals major Pfizer is considering cutting some of its activities in Germany due to government health reforms, according to a report in Die Welt...

Long-term plasmid storage feasible

27-Aug-2003 - Germany's PlasmidFactory has published long-term stability data for its plasmid DNA, which the company hopes will become an active pharmaceutical ingredient (API) for drugs such...

S-P cuts jobs to slash costs

25-Aug-2003 - Embattled pharmaceutical company Schering-Plough has lowered its financial forecasts for the second time and unveiled a fresh round of cost cutting in an attempt to...

Amcor expansion continues apace

25-Aug-2003 - Australian packaging group Amcor has entered into a A$330 million (€198m) agreement to buy Rexam's healthcare flexibles packaging business and will also buy out Danisco...

Zengen claims a first with drug-laden oral strip

25-Aug-2003 - Zengen of the USA has said that its technology has been used in a melt-in-the-mouth oral strip product, the first time that such a product...

Granules India opens world's largest PFI facility

25-Aug-2003 - Granules India has started commercial operations at its new pharmaceutical formulation intermediates (PFI) facility at Gagillapur near Hyderabad. The new unit with a capacity of...

Major MS component deal for Oxford Instruments

25-Aug-2003 - Oxford Instruments has won a €3 million order from Thermo Electron for the supply of superconducting magnets that will be used in the latter's recently...

Focus shift for Fugensoft

22-Aug-2003 - US e-business software company Fugensoft has revamped its product range, introducing a suite of new products and a change of focus, to meet the needs...

Capacity utilisation ups profit margins

22-Aug-2003 - Top pharmaceutical manufacturing plants strive to achieve efficient operations that result in increased profitability as well as superior product quality and satisfied customers. These are...

Aastrom gets go ahead for vaccine kits

22-Aug-2003 - US biopharmaceutical company Aastrom Biosciences has received approval to market and sell its DCV-II cancer vaccine production kits in the European Union. The third dendritic...

Market approval for SARS test

22-Aug-2003 - Abbott Laboratories and artus have gained European approval for their RealArt HPA Coronavirus LC RT Reagents, a diagnostic test for Severe Acute Respiratory Syndrome (SARS)....

S&N take stake in Portuguese brewery

21-Aug-2003 - Scottish & Newcastle, the UK brewing and leisure group, confirmed last week the acquisition of a 49 per cent stake in Central De Cervejas (Centralcer),...

Carlsberg bids for local rival

21-Aug-2003 - Carlsberg, the Danish brewer, announced last week a friendly takeover bid for Albani Brewery. The brewing giant offered DKr378m ($46m) for the company. But the...

BioProgress makes first system sales

20-Aug-2003 - BioProgress of the UK, which specialises in delivery mechanisms for the pharmaceutical oral dosage markets, has sold the first two machines in its line of...

Catalyst deal for Materia and Sigma

20-Aug-2003 - Sigma-Aldrich of the USA has negotiated an exclusive contract to distribute research quantities of a range of catalysts developed by Materia that are used in...

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products